Liver fibrosis: Noninvasive diagnosis with double contrast material-enhanced MR imaging

Radiology

Volumn 239, Issue 2, 2006, Pages 425-437

  Aguirre, Diego A ^a,b   Behling, Cynthia A ^a   Alpert, Elliot ^a   Hassanein, Tarek I ^a   Sirlin, Claude B ^a  

^a UCSD MEDICAL CENTER   (United States)

^b HOSPITAL UNIVERSITARIO FUNDACIÓN SANTA FE DE BOGOTÁ   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; SUPERPARAMAGNETIC IRON OXIDE;

ADULT; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; FEMALE; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RANK SUM TEST; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; REVIEW; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SIGNAL NOISE RATIO; SPOILED GRADIENT ECHO MAGNETIC RESONANCE IMAGING;

CONTRAST MEDIA; FEMALE; HUMANS; IRON; LIVER CIRRHOSIS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OXIDES; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES;

EID: 33646139892     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2392050505     Document Type: Review

References (43)

1. Afdhal NH, Nunes D. Evaluation of liver fibrosis: a concise review. Am J Gastroenterol 2004;99:1160-1174.
2. Talwalkar JA. Economic impact of hospitalization for end-stage liver disease. Am J Gastroenterol 2002;97:1562.
3. Talwalkar JA, Kim WR. Medical and economic impact of autoimmune hepatitis. Clin Liver Dis 2002;6:649-667.
4. Leads from the MMWR: trends in mortality from cirrhosis and alcoholism-United States, 1945-1983. JAMA 1986;256:3337-3338.
5. Perrault J, McGill DB, Ott BJ, Taylor WF. Liver biopsy: complications in 1000 inpatients and outpatients. Gastroenterology 1978;74:103-106.
6. Thampanitchawong P, Piratvisuth T. Liver biopsy: complications and risk factors. World J Gastroenterol 1999;5:301-304.
7. Little AK, Ferris JV, Dodd GD 3rd, Baron RL. Image-guided percutaneous hepatic biopsy: effect of ascites on the complication rate. Radiology 1996;199:79-83.
8. Lindor KD, Brn C, Jorgensen RA, et al. The role of ultrasonography and automatic-needle biopsy in outpatient percutaneous liver biopsy. Hepatology 1996;23:1079-1083.
9. Froehlich F, Lamy O, Fried M, Gonvers JJ. Practice and complications of liver biopsy: results of a nationwide survey in Switzerland. Dig Dis Sci 1993;38:1480-1484.
10. Terjung B, Lemnitzer I, Dumoulin FL, et al. Bleeding complications after percutaneous liver biopsy: an analysis of risk factors. Digestion 2003;67:138-145.
11. Bruguera M, Bordas JM, Mas P, Rodes J. A comparison of the accuracy of peritoneoscopy and liver biopsy in the diagnosis of cirrhosis. Gut 1974;15:799-800.
12. Poniachik J, Bernstein DE, Reddy KR, et al. The role of laparoscopy in the diagnosis of cirrhosis. Gastrointest Endosc 1996;43: 568-571.
13. Pagliaro L, Rinaldi F, Craxi A, et al. Percutaneous blind biopsy versus laparoscopy with guided biopsy in diagnosis of cirrhosis: a prospective, randomized trial. Dig Dis Sci 1983; 28:39-43.
14. Olsson R, Hagerstrand I, Broome U, et al. Sampling variability of percutaneous liver biopsy in primary sclerosing cholangitis. J Clin Pathol 1995;48:933-935.
15. Maharaj B, Maharaj RJ, Leary WP, et al. Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet 1986;1:523-525.
16. Angelucci E, Baronciani D, Lucarelli G, et al. Needle liver biopsy in thalassaemia: analyses of diagnostic accuracy and safety in 1184 consecutive biopsies. Br J Haematol 1995; 89:757-761.
17. Annet L, Materne R, Danse E, Jamart J, Horsmans Y, Van Beers BE. Hepatic flow parameters measured with MR imaging and Doppler US: correlations with degree of cirrhosis and portal hypertension. Radiology 2003;229:409-414.
18. Ito K, Mitchell DG, Hann HW, et al. Viral-induced cirrhosis: grading of severity using MR imaging. AJR Am J Roentgenol 1999; 173:591-596.
19. Awaya H, Mitchell DG, Kamishima T, Holland G, Ito K, Matsumoto T. Cirrhosis: modified caudate-right lobe ratio. Radiology 2002;224:769-774.
20. Anbe C, Oberti F, Korali N, et al. Ultrasonographic diagnosis of hepatic fibrosis or cirrhosis. J Hepatol 1999;30:472-478.
21. Elizondo G, Weissleder R, Stark DD, et al. Hepatic cirrhosis and hepatitis: MR imaging enhanced with superparamagnetic iron oxide. Radiology 1990;174:797-801.
22. Lucidarme O, Baleston F, Cadi M, et al. Non-invasive detection of liver fibrosis: is superparamagnetic iron oxide particle-enhanced MR imaging a contributive technique? Eur Radiol 2003;13:467-474.
23. Senielka RC, Chung JJ, Hussain SM, Marcos HB, Woosley JT. Chronic hepatitis: correlation of early patchy and late linear enhancement patterns on gadolinium-enhanced MR images with histopathology initial experience. J Magn Reson Imaging 2001;13:385-391.
24. Oswald P, Clement O, Chambon C, Schouman-Claeys E, Frija G. Liver positive enhancement after injection of superparamagnetic nanoparticles: respective role of circulating and uptaken particles. Magn Reson Imaging 1997;15:1025-1031.
25. Tanimoto A, Yuasa Y, Shimnoto H, et al. Superparamagnetic iron oxide-mediated hepatic signal intensity change in patients with and without cirrhosis: pulse sequence effects and Kupffer cell function. Radiology 2002; 222:661-666.
26. Hundt W, Petsch R, Helmberger T, Reiser M. Signal changes in liver and spleen after Endorem administration in patients with and without liver cirrhosis. Eur Radiol 2000;10; 409-410.
27. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C: the OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 1997;349:825-832.
28. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983;148:839-843.
29. Obuchowski NA. Receiver operating characteristic curves and their use in radiology. Radiology 2003;229:3-8.
30. Afdhal NH. Biopsy or biomarkers: is there a gold standard for diagnosis of liver fibrosis? Clin Chem 2004;50:1299-1300.
31. Colli A, Fraquelli M, Andreolotti M, Marino B, Zuccoli E, Conte D. Severe liver fibrosis or cirrhosis: accuracy of US for detection-analysis of 300 cases. Radiology 2003;227: 89-94.
32. Lu LG, Zeng MD, Wan MB, et al. Grading and staging of hepatic fibrosis, and its relationship with noninvasive diagnostic parameters. World J Gastroenterol 2003;9:2574-2578.
33. Imbert-Bismut F, Ratzin V, Pieroni L, Charlotte F, Benhamou Y, Poynard T. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 2001;357:1069-1075.
34. Oberti F, Valsesia E, Pilette C, et al. Noninvasive diagnosis of hepatic fibrosis or cirrhosis. Gastroenterology 1997;113:1609-1616.
35. Di Lelio A, Cestari C, Lomazzi A, Beretta L. Cirrhosis: diagnosis with sonographic study of the liver surface. Radiology 1989;172: 389-392.
36. Hussain HK, Syed I, Nghiem HV, et al. T2-weighted MR imaging in the assessment of cirrhotic liver. Radiology 2004;230:637-644.
37. Ito K, Mitchell DG, Gabata T, Hussain SM. Expanded gallbladder fossa: simple MR imaging sign of cirrhosis. Radiology 1999;211: 723-726.
38. Boulanger Y, Amara M, Lepanto L, et al. Diffusion-weighted MR imaging of the liver of hepatitis C patients. NMR Biomed 2003; 16:132-130.
39. Jirak D, Dezortova M, Taimr P, Hajek M. Texture analysis of human liver. J Magn Reson Imaging 2002;15:68-74.
40. Jirak D, Dezortova M, Taimr P, Hajek M. Texture analysis of human liver. J Magn Reson Imaging 2002;15:68-74.
41. Ide M, Yamate J, Machida Y, et al. Emergence of different macrophage populations in hepatic fibrosis following thioacetamide-induced acute hepatocyte injury in rats. J Comp Pathol 2003;128:41-51.
42. Lieber CS. Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. Alcohol 2004;34:9-19.
43. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C: the French METAVIR Cooperative Study Group. Hepatology 1994; 20:15-20.